Paris Panayiotopoulos

Président chez FerGene, Inc.

Profil

Paris Panayiotopoulos was the founder of Anthos Therapeutics, Inc., founded in 2019, serving as Director from 2019 to 2025.
Mr. Panayiotopoulos was the founder of AvenCell Therapeutics, Inc., founded in 2021, serving as Director.
Current jobs include Co-Chairman at FerGene, Inc., Director at European Pharmaceutical Market Research Association, Senior Managing Director at Blackstone Life Sciences Advisors LLC since 2018, and Member at Chamber of Commerce of The United States of America.
Former jobs include President, Chief Executive Officer & Director at ARIAD Pharmaceuticals, Inc. from 2016 to 2017; Chairman at Genevant Sciences Corp.
from 2018 to 2020; Director at The Medicines Co. from 2017 to 2020; Director at Biotechnology Innovation Organization; Independent Director at Corbus Pharmaceuticals Holdings, Inc. from 2017 to 2020; Chief of Staff at Merck KGaA from 2012 to 2013; Principal at Eli Lilly & Co. Ltd. from 1999 to 2004; President at EMD Serono, Inc. from 2014 to 2016; Partner at Clarus Ventures LLC in 2018; and President at Merck Serono Co., Ltd. from 2013 to 2014.
Education includes an undergraduate degree from University College London in 1996 and a graduate degree from Cranfield School of Management in 1997.

Postes actifs de Paris Panayiotopoulos

Sociétés	Poste	Début
European Pharmaceutical Market Research Association	Directeur/Membre du Conseil	-
Chamber of Commerce of The United States of America	Corporate Officer/Principal	-
FerGene, Inc.	Président	-
Blackstone Life Sciences Advisors LLC	Private Equity Investor	01/12/2018

Anciens postes connus de Paris Panayiotopoulos

Sociétés	Poste	Fin
Anthos Therapeutics, Inc.	Fondateur	01/04/2025
Genevant Sciences Corp.	Président	31/07/2020
CORBUS PHARMACEUTICALS HOLDINGS, INC.	Directeur/Membre du Conseil	06/03/2020
THE MEDICINES COMPANY	Directeur/Membre du Conseil	31/01/2020
Clarus Ventures LLC	Private Equity Investor	30/11/2018